AKTE THERAPEUTICS
Who is AKTE THERAPEUTICS?
Akte Therapeutics is developing epigenetic therapies to boost protein production to halt/reverse monogenic diseases. Our platform overcomes the limitations of existing therapeutic approaches to provide treatments for patients in need.
Industry & Specialities
Others
Countries of Operation
Australia
Headquarters:
Australia
Company Type:
SME
Company size:
1-10 Employees
Year Founded:
2023 (3 years)
Address:
SYDNEY, AU
Employees by Department
- The Rest (1)
- Total (1)
Key Decision Makers
Thomas Mitchell
CEO, Chairman, & Co-Founder
Employees by Seniority
C-level
1employees
Senior
0employees
Non-managers
0employees
Financials
LOW
spending power
Funding Status
Private
Associated Legal Entities
0 entities
Discover More Companies
Lookalike companies
Featured Lists
- SMEs in Singapore
- MNCs / Large Enterprises in Singapore
Frequently Asked Questions (FAQ)
- How long has AKTE THERAPEUTICS been operating for?
- What is the funding status of AKTE THERAPEUTICS?
- Where is AKTE THERAPEUTICS's headquarter?
- What AKTE THERAPEUTICS's spending power?
- Does AKTE THERAPEUTICS have a presence in the domain it operates in?